Ronald G. Sherrill

Synthesis and anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one (TIBO) derivatives. 2

Michael J. Kukla, Henry J. Breslin, Craig J. Diamond et al. · Journal of Medicinal Chemistry · 1991 · 166 citations

Pharmacy, Chemistry, Medicinal Chemistry +12

Synthesis and anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one (TIBO) derivatives

Michael J. Kukla, Henry J. Breslin, Rudi Pauwels et al. · Journal of Medicinal Chemistry · 1991 · 92 citations

Pharmacy, Medicinal Chemistry, Pharmacology +6

Optimization of 3-(1<i>H</i>-Indazol-3-ylmethyl)-1,5-benzodiazepines as Potent, Orally Active CCK-A Agonists

Brad R. Henke, Christopher Aquino, Larry S. Birkemo et al. · Journal of Medicinal Chemistry · 1997 · 86 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Ultra-potent P1 modified arylsulfonamide HIV protease inhibitors: The discovery of GW0385

John F. Miller, C. Webster Andrews, Michael Brieger et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 78 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

The Naphthyridinone GSK364735 Is a Novel, Potent Human Immunodeficiency Virus Type 1 Integrase Inhibitor and Antiretroviral

Edward P. Garvey, Brian A. Johns, Margaret Gartland et al. · Antimicrobial Agents and Chemotherapy · 2007 · 76 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17